Frameworks and Strategies to Improve Inclusion of Underserved Groups in Myeloma Clinical Trials (EQUAL-ME Project): A Scoping Review Protocol

Key Points

• Improving inclusion of underserved groups in myeloma clinical trials is vital for equitable healthcare access.
• Key evidence shows insufficient representation of diverse populations in clinical trials increases health disparities.
• Scoping review protocol developed to identify frameworks and strategies that enhance participation in clinical trials.
• May enable more effective clinical trials by addressing inequality in access and representation of underserved groups.